Ann: Annual Report to Shareholders, page-56

This is likely the 3rd time that I have posted this Challenge.

To date I have not had any respondents.

Please advise;

A comparable company to IHL with a Market Cap of less than US$1 BLN?

With a similar development pipeline?
With a TAM's in excess of US$110 BLN?
With trials of similar POS (probability of success)

(Please do not compare IHL with established company's - revenues, we know that is not how you value a biotech in development stage)

I am genuinely interested to know the answer, so we can all compare and contrast the differences for good Due Diligence?

Good luck all